Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127181811 | 12718181 | 1 | I | 2015 | 20160829 | 20160906 | 20160906 | EXP | US-ASTRAZENECA-2016SE92693 | ASTRAZENECA | 60.00 | YR | F | Y | 0.00000 | 20160906 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127181811 | 12718181 | 1 | PS | FASLODEX | FULVESTRANT | 1 | Intramuscular | 125 MG/2.5 MONTHLY | U | U | 21344 | INJECTION | |||||||
| 127181811 | 12718181 | 2 | C | AROMASIN | EXEMESTANE | 1 | 0 | ||||||||||||
| 127181811 | 12718181 | 3 | C | PERJETA | PERTUZUMAB | 1 | 6(8 LD)- Q21D X 6 | 0 | |||||||||||
| 127181811 | 12718181 | 4 | C | HERCEPTIN | TRASTUZUMAB | 1 | 0 | ||||||||||||
| 127181811 | 12718181 | 5 | C | LETROZOLE. | LETROZOLE | 1 | 0 | ||||||||||||
| 127181811 | 12718181 | 6 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 0 | 4 | MG | TABLET | Q6H | |||||||
| 127181811 | 12718181 | 7 | C | PREVIDENT | SODIUM FLUORIDE | 1 | Dental | 0 | |||||||||||
| 127181811 | 12718181 | 8 | C | FENTANYL. | FENTANYL | 1 | Transdermal | ONE PATCH EVERY 3 DAYS :25 MCG/FLR | 0 | TRANSDERMAL PATCH | |||||||||
| 127181811 | 12718181 | 9 | C | FENTANYL. | FENTANYL | 1 | Transdermal | ONCE EVERY THREE DAYS 25 MCG/HR | 0 | TRANSDERMAL PATCH | |||||||||
| 127181811 | 12718181 | 10 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 127181811 | 12718181 | 11 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | Q+6 HOURS PRN PAIN 5-325 RNG | 0 | TABLET | |||||||||
| 127181811 | 12718181 | 12 | C | OXYCODONE-ACETAMINOPHEN | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | ONCE EVERY 6 FLOURS ONLY AS NEEDED FOR PAIN 5-325 MG | 0 | TABLET | |||||||||
| 127181811 | 12718181 | 13 | C | EMLA | LIDOCAINEPRILOCAINE | 1 | Topical | APPLY 1 HOUR PRIOR TO FASLODEX INJECTION 2 .5-2.5 % | 0 | ||||||||||
| 127181811 | 12718181 | 14 | C | XGEVA | DENOSUMAB | 1 | Subcutaneous | 6 WEEKS | 0 | ||||||||||
| 127181811 | 12718181 | 15 | C | MS CONTIN | MORPHINE SULFATE | 1 | Oral | 0 | 1 | DF | TABLET | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127181811 | 12718181 | 1 | Breast cancer metastatic |
| 127181811 | 12718181 | 2 | Breast cancer metastatic |
| 127181811 | 12718181 | 3 | Breast cancer metastatic |
| 127181811 | 12718181 | 4 | Breast cancer metastatic |
| 127181811 | 12718181 | 12 | Pain |
| 127181811 | 12718181 | 15 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127181811 | 12718181 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127181811 | 12718181 | Back pain | |
| 127181811 | 12718181 | Malignant neoplasm progression | |
| 127181811 | 12718181 | Metastases to bone | |
| 127181811 | 12718181 | Metastases to breast | |
| 127181811 | 12718181 | Metastases to lymph nodes |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127181811 | 12718181 | 1 | 20160113 | 0 | ||
| 127181811 | 12718181 | 3 | 20150708 | 0 | ||
| 127181811 | 12718181 | 14 | 20160113 | 0 |